Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Year: 2017
Type: article
Authors: Jason Grebely, Julie Bruneau, Jeffrey V. Lazarus, Olav Dalgard, Philip Bruggmann, Carla Treloar, Matthew Hickman, Margaret Hellard, Teri Roberts, Levinia Crooks, Håvard Midgard, Sarah Larney, Louisa Degenhardt, Hannu Alho, Jude Byrne, John F. Dillon, Jordan J. Feld, Graham Foster, David Goldberg, Andrew R. Lloyd, Jens Reimer, Geert Robaeys, Marta Torrens, Nat Wright, Icro Maremmani, Brianna L. Norton, Alain H. Litwin, Gregory J. Dore
Institutions: UNSW Sydney, Kirby Institute, Centre Hospitalier de l’Université de Montréal, Université de Montréal, University of Copenhagen, Rigshospitalet, Hospital Clínic de Barcelona, Barcelona Institute for Global Health, Centre of Excellence for Health, Immunity and Infections, University of Oslo, Akershus University Hospital, Arud, University of Bristol, Burnet Institute, Médecins Sans Frontières, Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Oslo University Hospital, National Drug and Alcohol Research Centre, University of Helsinki, Helsinki University Hospital, Finnish Institute for Health and Welfare, Ninewells Hospital, University of Toronto, Queen Mary University of London, Glasgow Caledonian University, Health Protection Scotland, University Medical Center Hamburg-Eppendorf, Universitair Ziekenhuis Leuven, Ziekenhuis Oost-Limburg, Hasselt University, Universitat Autònoma de Barcelona, Hospital Del Mar, Parc de Salut, Municipal Institute for Medical Research, Hospital del Mar Research Institute, Spectrum Community Health CIC, University of Pisa, Albert Einstein College of Medicine, Montefiore Medical Center
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Intensive Models of HCV Care for Injection Drug Users, NIHR Senior Investigator Award, Adaptation and testing of a primary care HCV group medical treatment intervention, Can HCV treatment be delivered to injecting drug users in order to reduce HCV transmission and prevalence in the population: an empirical demonstration and evaluation
OpenAlex ID: W2729748948